Search
for
Sort by
Research 361–390 of 1000+
- Alopecia With Endocrine Therapies in Patients With Cancer
- Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata
- Alopecia Areata: Treatment of Today and Tomorrow
- Alopecia areata: diagnosis and management
- Treatment of widespread alopecia areata in young patients with monthly oral corticosteroid pulse.
- Treatment of pediatric alopecia areata: A systematic review
- Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis
- Loss of Vascular Endothelial Growth Factor in Human Alopecia Hair Follicles
- New and Emerging Therapies for Alopecia Areata
- Serological screening for coeliac disease in vitiligo and alopecia areata
- Alopecia Areata in Korea (1982–1994)
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Pathomechanisms of immune-mediated alopecia
- Platelet-rich plasma injection is effective and safe for the treatment of alopecia
- Hypertension and aldosterone levels in women with early-onset androgenetic alopecia
- Treatment of persistent alopecia areata with sulfasalazine
- Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety
- Efficacy and safety of methotrexate in alopecia areata
- Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata
- Major Histocompatibility Complex Class I Chain-Related Gene A Polymorphisms and Extended Haplotypes Are Associated with Familial Alopecia Areata
- Acquired scalp alopecia. Part I: A review
- Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series
- Alopecia in patients treated with molecularly targeted anticancer therapies
- The genetics of alopecia areata: What's new and how will it help our patients?
- Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?
- Environmental stress but not subjective distress in children or adolescents with alopecia areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- ‘Black dots’ seen under trichoscopy are not specific for alopecia areata
- Diagnosis and Management of Primary Cicatricial Alopecia: Part I